Trump Diagnosed with Chronic Venous Insufficiency
The White House announced on July 17, 2025, that President Donald Trump has been diagnosed with chronic venous insufficiency (CVI), a common circulatory condition. Press Secretary Karoline Leavitt confirmed the diagnosis during a briefing in Washington, D.C., following public observations of swelling in the president’s lower legs.
Chronic venous insufficiency occurs when the valves in the leg veins weaken or become damaged, impairing the return of blood to the heart. This leads to blood pooling in the lower extremities, often causing swelling (edema), a heavy or achy sensation, and in some cases, skin changes or varicose veins. The condition is particularly prevalent in individuals over 70, and Trump was 79 at the time of diagnosis.
Doctors conducted a thorough medical evaluation, including bilateral lower extremity venous Doppler ultrasounds. The tests confirmed CVI but explicitly ruled out more serious concerns, such as deep vein thrombosis (DVT), arterial disease, or any cardiac issues. An echocardiogram showed normal heart structure and function. White House physicians described the condition as “benign and common,” emphasizing that Trump remains in excellent overall health.
The announcement came after recent public appearances where observers noted Trump moving more slowly and visible swelling around his ankles. Images circulating online also showed bruising on his hands, which officials attributed to frequent handshaking combined with his daily use of aspirin for cardiovascular prevention. Leavitt stressed that the evaluation was performed “out of an abundance of caution.”
Officials reassured the public that CVI is manageable and does not threaten the president’s ability to perform his duties. Standard management typically includes compression stockings, leg elevation, regular walking to improve circulation, weight management, and monitoring. Trump is receiving appropriate care, and his active schedule during a demanding period continues uninterrupted.
The diagnosis generated significant online reaction, with supporters trending hashtags such as #TrumpStrong and offering messages of encouragement. While the condition requires ongoing attention, medical experts note it is rarely life-threatening when properly managed.
This health disclosure highlights a broader truth: even national leaders are subject to age-related medical conditions. The White House’s prompt communication aimed to promote transparency and maintain public confidence. As of early 2026, the condition has been described as stable with no reported complications affecting Trump’s overall health or performance.
The announcement serves as a reminder that proactive medical evaluation remains essential, even for those in high-pressure roles. Updates will be provided as needed while President Trump continues to fulfill his responsibilities.
